Improved Alertness Is Associated with Early Increase in Serum Brain-Derived Neurotrophic Factor and Antidepressant Treatment Outcome in Major Depression
暂无分享,去创建一个
J. Beck | U. Hemmeter | S. Brand | E. Holsboer-trachsler | T. Mikoteit | A. Delini-Stula | R. Bischof | A. Eckert
[1] Leanne M Williams,et al. A Cognitive–Emotional Biomarker for Predicting Remission with Antidepressant Medications: A Report from the iSPOT-D Trial , 2015, Neuropsychopharmacology.
[2] Faith M. Gunning-Dixon,et al. Executive functioning complaints and escitalopram treatment response in late-life depression. , 2015, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[3] M. Banasr,et al. BDNF Release Is Required for the Behavioral Actions of Ketamine , 2014, The international journal of neuropsychopharmacology.
[4] J. Beck,et al. Fast BDNF serum level increase and diurnal BDNF oscillations are associated with therapeutic response after partial sleep deprivation. , 2014, Journal of psychiatric research.
[5] V. Camus,et al. The BDNF Val66Met polymorphism is associated with escitalopram response in depressed patients , 2014, Psychopharmacology.
[6] B. Penninx,et al. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484) , 2014, Molecular Psychiatry.
[7] M. Nitsche,et al. BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: Results from a factorial, randomized, sham-controlled trial , 2014, European Neuropsychopharmacology.
[8] J. Beck,et al. High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression , 2014, Psychopharmacology.
[9] A. Gade,et al. The cumulative load of depressive illness is associated with cognitive function in the remitted state of unipolar depressive disorder , 2013, European Psychiatry.
[10] J. Flory,et al. The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Moderates an Effect of Physical Activity on Working Memory Performance , 2013, Psychological science.
[11] S. Brand,et al. Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only. , 2013, Journal of psychiatric research.
[12] B. Abler,et al. Modulation of attention network activation under antidepressant agents in healthy subjects. , 2013, The international journal of neuropsychopharmacology.
[13] G. Aghajanian,et al. Synaptic Dysfunction in Depression: Potential Therapeutic Targets , 2012, Science.
[14] R. Lee,et al. A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder. , 2012, Journal of affective disorders.
[15] R. Hellweg,et al. Changes of Serum Concentrations of Brain-Derived Neurotrophic Factor (BDNF) during Treatment with Venlafaxine and Mirtazapine: Role of Medication and Response to Treatment , 2012, Pharmacopsychiatry.
[16] J. Sneed,et al. Executive dysfunction and treatment response in late‐life depression , 2012, International journal of geriatric psychiatry.
[17] U. Knorr,et al. Decreased levels of brain‐derived neurotrophic factor in the remitted state of unipolar depressive disorder , 2012, Acta psychiatrica Scandinavica.
[18] Serap Yıldırım,et al. Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder , 2012, Brain Research Bulletin.
[19] A. Gade,et al. Cognitive deficits in the remitted state of unipolar depressive disorder. , 2012, Neuropsychology.
[20] G. Aghajanian,et al. Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex , 2012, Biological Psychiatry.
[21] Weimo Zhu. Sadly, the earth is still round ( p < 0.05) , 2012 .
[22] R. Tabarés-Seisdedos,et al. The Clinical Implications Of Cognitive Impairment and Allostatic Load in Bipolar Disorder , 2013, European Psychiatry.
[23] R. Milev,et al. Effects of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation on Serum Brain-Derived Neurotrophic Factor Levels in Patients with Depression , 2012, Front. Psychiatry.
[24] U. Knorr,et al. Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review. , 2011, Journal of affective disorders.
[25] C. Laske,et al. Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients. , 2011, The international journal of neuropsychopharmacology.
[26] B. Penninx,et al. The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val66Met , 2010, Psychopharmacology.
[27] J. Buitelaar,et al. Determinants of serum brain-derived neurotrophic factor , 2011, Psychoneuroendocrinology.
[28] G. MacQueen,et al. Clinical Factors That Predict Cognitive Function in Patients with Major Depression , 2010, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[29] M. Hoptman,et al. BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression. , 2010, Journal of affective disorders.
[30] Nanxin Li,et al. mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists , 2010, Science.
[31] D. Ye,et al. Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder , 2010, European Neuropsychopharmacology.
[32] E. Gudayol-Ferré,et al. Effects of selective serotonin reuptake and dual serotonergic–noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder , 2010, Psychiatry Research.
[33] S. U. Kaymak,et al. Hippocampus, glucocorticoids and neurocognitive functions in patients with first-episode major depressive disorders , 2010, European Archives of Psychiatry and Clinical Neuroscience.
[34] Alberto Pilotto,et al. Late-life depression, mild cognitive impairment, and dementia: possible continuum? , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[35] Richard J Porter,et al. Longitudinal Assessment of Neuropsychological Function in Major Depression , 2009, The Australian and New Zealand journal of psychiatry.
[36] C. Marra,et al. Correlations between peripheral blood mononuclear cell production of BDNF, TNF‐alpha, IL‐6, IL‐10 and cognitive performances in multiple sclerosis patients , 2009, Journal of neuroscience research.
[37] Miou Zhou,et al. Positive AMPA Receptor Modulation Rapidly Stimulates BDNF Release and Increases Dendritic mRNA Translation , 2009, The Journal of Neuroscience.
[38] E. Gudayol-Ferré,et al. Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. , 2009, Journal of psychiatric research.
[39] A. Cattaneo,et al. Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants , 2009, BMC Neuroscience.
[40] Pingyuan Gong,et al. Effect of BDNF Val66Met Polymorphism on Digital Working Memory and Spatial Localization in a Healthy Chinese Han Population , 2009, Journal of Molecular Neuroscience.
[41] R. Lam,et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. , 2009, The international journal of neuropsychopharmacology.
[42] J. Becker,et al. Patterns of mild cognitive impairment after treatment of depression in the elderly. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[43] R. Post,et al. Allostatic load in bipolar disorder: Implications for pathophysiology and treatment , 2008, Neuroscience & Biobehavioral Reviews.
[44] Felipe Fregni,et al. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. , 2008, The international journal of neuropsychopharmacology.
[45] Tuomo Hänninen,et al. BDNF is a novel marker of cognitive function in ageing women: The DR’s EXTRA Study , 2008, Neurobiology of Learning and Memory.
[46] R. Duman,et al. Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications , 2008, Biological Psychiatry.
[47] W. Newbury,et al. Management of recurrent depression. , 2008, Australian family physician.
[48] Zhijun Zhang,et al. Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. , 2008, The Journal of clinical psychiatry.
[49] S. Reppermund,et al. Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis , 2008, Psychological Medicine.
[50] J. Mann,et al. Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects , 2008, Journal of Neural Transmission.
[51] P Rabbitt,et al. Brain‐derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly , 2008, Genes, brain, and behavior.
[52] M. Bajbouj,et al. Acute prefrontal cortex transcranial magnetic stimulation in healthy volunteers: no effects on brain-derived neurotrophic factor (BDNF) concentrations in serum. , 2008, Journal of affective disorders.
[53] I. Heuser,et al. Serum Concentrations of Nerve Growth Factor and Brain-Derived Neurotrophic Factor in Depressed Patients before and after Antidepressant Treatment , 2008, Pharmacopsychiatry.
[54] J. Suvisaari,et al. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. , 2008, Journal of affective disorders.
[55] Patrick Dattalo,et al. Statistical Power Analysis , 2008 .
[56] D. Helmeste,et al. Influence of exercise on serum brain-derived neurotrophic factor concentrations in healthy human subjects , 2008, Neuroscience Letters.
[57] R. Porter,et al. Neuropsychological Impairment in Major Depression: Its Nature, Origin and Clinical Significance , 2007, Australian and New Zealand journal of psychiatry (Print).
[58] Judith Jaeger,et al. Neurocognitive deficits and disability in major depressive disorder , 2006, Psychiatry Research.
[59] M. Bartels,et al. Stage-dependent BDNF serum concentrations in Alzheimer’s disease , 2006, Journal of Neural Transmission.
[60] H. Wagner,et al. Persistent mild cognitive impairment in geriatric depression , 2006, International Psychogeriatrics.
[61] R. Duman,et al. A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.
[62] Johannes Pohl,et al. Attention and executive functions in remitted major depression patients. , 2005, Journal of affective disorders.
[63] Faith M. Gunning-Dixon,et al. Executive Dysfunction and the Course of Geriatric Depression , 2005, Biological Psychiatry.
[64] L. Lázaro,et al. Neuropsychological prediction of recovery in late‐onset major depression , 2005, International journal of geriatric psychiatry.
[65] C. Bramham,et al. BDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis , 2005, Progress in Neurobiology.
[66] B. Singer,et al. Increase in epinephrine excretion is associated with cognitive decline in elderly men: MacArthur studies of successful aging , 2005, Psychoneuroendocrinology.
[67] J. Gorman,et al. The role of executive functioning in CBT: a pilot study with anxious older adults. , 2005, Behaviour research and therapy.
[68] Anirvan Ghosh,et al. BDNF regulates primary dendrite formation in cortical neurons via the PI3-kinase and MAP kinase signaling pathways. , 2005, Journal of neurobiology.
[69] F. Holsboer,et al. Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders , 2004, Psychological Medicine.
[70] L. Speedie,et al. Neuropsychological functioning in major depression and responsiveness to selective serotonin reuptake inhibitors antidepressants. , 2004, Journal of affective disorders.
[71] A. Mørk,et al. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels , 2004, Brain Research.
[72] J. Virchow,et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma , 2004, Neurobiology of Aging.
[73] C. Sutcliffe,et al. Treatment response in late-onset depression: relationship to neuropsychological, neuroradiological and vascular risk factors , 2004, Psychological Medicine.
[74] J. Jolles,et al. Cognitive functioning in young and middle-aged unmedicated out-patients with major depression: testing the effort and cognitive speed hypotheses , 2003, Psychological Medicine.
[75] Stephen M Stahl,et al. Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. , 2003, The Journal of clinical psychiatry.
[76] S. Zeiler,et al. Development/Plasticity/Repair Brain-Derived Neurotrophic Factor Is Required for the Maintenance of Cortical Dendrites , 2022 .
[77] Til Wykes,et al. Effects of depressed mood on objective and subjective measures of attention. , 2003, The Journal of neuropsychiatry and clinical neurosciences.
[78] M. Egan,et al. The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.
[79] D. Wong,et al. Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal Receptors , 2001, Neuropsychopharmacology.
[80] A. Leuchter,et al. Executive dysfunction predicts nonresponse to fluoxetine in major depression. , 2000, Journal of affective disorders.
[81] F. Hallböök. Evolution of the vertebrate neurotrophin and Trk receptor gene families , 1999, Current Opinion in Neurobiology.
[82] B. Lu,et al. Neurotrophins and hippocampal synaptic transmission and plasticity , 1999, Journal of neuroscience research.
[83] B. McEwen,et al. Stress and the individual. Mechanisms leading to disease. , 1993, Archives of internal medicine.
[84] B. Lu,et al. BDNF and synaptic plasticity, cognitive function, and dysfunction. , 2014, Handbook of experimental pharmacology.
[85] Hannah R. Snyder. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. , 2013, Psychological bulletin.
[86] M. Husain,et al. Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. , 2010, Neuropsychology.
[87] R. Shelton,et al. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. , 2009, Journal of psychiatric research.
[88] F. Quitkin,et al. Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients. , 2006, The American journal of psychiatry.
[89] B. Gillain,et al. Effects of sertraline on depressive symptoms and attentional and executive functions in major depression , 2005, Depression and anxiety.
[90] J. Cooper. Pocket guide to the ICD-10 classification of mental and behavioural disorders : with glossary and diagnostic criteria for research : ICD-10:DCR-10 , 1994 .